The answer was always YES, after arrival already at the reception, NO
By staying informed, tracking symptoms, and working with healthcare professionals, people using both medications can confidently manage their health and reduce risks while benefiting from the purpose of each treatment
Retrospective EHR-based studies can capture real-world associations, yet they are especially vulnerable to residual confounding, treatment-selection bias, differences in healthcare engagement, and unmeasured disease biology
Food and Drug Administration FDA approves first oral GLP-1 treatment for type 2 diabetes
At LVWellness & Aesthetics, we believe in a holistic approach to wellness
Happy to be a client at Green Relief